Table 1 Characteristics of included studies
From: Guidelines are needed for studies of pre-treatment HIV drug resistance: a methodological study
Variable | Statistic (N = 234) |
|---|---|
Year of publication: median (q1; q3) | 2013 (2009;2015) |
Sample size: median (q1; q3) | 239 (101;778) |
Income: n (%) | |
High | 125 (53.4) |
Upper middle | 86 (36.8) |
Lower middle | 16 (6.8) |
Low | 3 (1.3) |
Multiple | 4 (1.7) |
Region: n (%) | |
Africa | 7 (3.0) |
America | 68 (29.1) |
Eastern Mediterranean | 4 (1.7) |
Europe | 82 (35.0) |
South East Asia | 12 (5.1) |
Western Pacific | 56 (23.9) |
Multiplea | 5 (2.1) |
Funding: n (%) | |
Not reported | 121 (51.7) |
Government | 51 (21.8) |
Multiplea | 3 (1.3) |
Industry | 19 (8.1) |
Private | 40 (17.1) |